Оземпик без иллюзий: Гонка за волшебным средством для похудения

Lekarstvo ot ozhyrenyya dolgoe vremya bylo svyashchennym Graalem dlya farmatsevtycheskoy promyshlennosty, kazavshymsya nedostyzhymym do nedavnykh proryvov v yssledovanyyakh dyabeta 2 typa, kotorye pryvely k razrabotke Ozempyka — preparata dlya pokhudenyya, aktyvyruyushchego gormon GLP-1 v zheludke, blagodarya chemu lyudy dolshe chuvstvuyut sebya sytymy. Lechenye nastolko effektyvno, chto uzhe menyaet mnogye otrasly — ot zdravookhranenyya do fast-fuda y mody — y bystro sdelalo ego sozdatelya, datskuyu kompanyyu Novo Nordisk, samoy dorogoy kompanyey v Evrope. No po mere poyavlenyya novykh potentsyalnykh preymushchestv, v umakh lyudey voznykaet vopros: ne slyshkom ly khoroshy ety preparaty, chtoby byt pravdoy?V knyge «Ozempyk bez yllyuzyy» zhurnalystka Reuters Eymy Donnellan osveshchaet ystoryyu medytsynskogo proryva, sposobnogo yzmenyt myr, y podnymaet slozhnye voprosy o prynyatyy svoego tela, neystovomu zhelanyyu pokhudet tsenoy tyazheleyshykh pobochnykh deystvyy. Blagodarya realnym ystoryyam lyudey y tshchatelnym nauchnym yssledovanyyam, ona prognozyruet budushchee volshebnogo kyshechnogo gormona GLP-1.

A cure for obesity has long been the holy Grail for the pharmaceutical industry, seemingly unattainable until recent breakthroughs in type 2 diabetes research, which led to the development of Ozempika, a weight—loss drug that activates the hormone GLP-1 in the stomach, making people feel full longer. The treatment is so effective that it is already changing many industries — from healthcare to fast food and fashion - and has quickly made its creator, the Danish company Novo Nordisk, the most expensive company in Europe. But as new potential benefits emerge, the question arises in people's minds: aren't these drugs too good to be true?In the book "Ozempik without Illusions," Reuters journalist Aimee Donnellan highlights the story of a medical breakthrough that could change the world, and raises difficult questions about accepting your body and the frantic desire to lose weight at the cost of severe side effects. Thanks to real people's stories and rigorous scientific research, she predicts the future of the magical intestinal hormone GLP-1.